LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 254 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 3.89 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $231,000 | -1.3% | 2,184 | -5.1% | 0.03% | +7.7% |
| Q4 2016 | $234,000 | -31.4% | 2,302 | -31.0% | 0.03% | -16.1% |
| Q3 2016 | $341,000 | -36.0% | 3,338 | -25.3% | 0.03% | -35.4% |
| Q2 2016 | $533,000 | -39.8% | 4,471 | -46.0% | 0.05% | -35.1% |
| Q1 2016 | $886,000 | -43.2% | 8,278 | -42.5% | 0.07% | -35.1% |
| Q4 2015 | $1,561,000 | -69.5% | 14,399 | -75.9% | 0.11% | -40.0% |
| Q3 2015 | $5,126,000 | – | 59,858 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $6,891 | 2.63% |
| VILLERE ST DENIS J & CO LLC | 438,161 | $26,254,607 | 2.24% |
| RICE HALL JAMES & ASSOCIATES, LLC | 282,961 | $16,955,023 | 1.08% |
| Chicago Capital, LLC | 360,345 | $21,591,884 | 1.01% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 206,399 | $12,367,428 | 0.53% |
| Smith, Graham & Co., Investment Advisors, LP | 61,849 | $3,705,992 | 0.46% |
| Stephens Investment Management Group LLC | 467,564 | $28,016,435 | 0.46% |
| Jackson Creek Investment Advisors LLC | 13,657 | $818 | 0.34% |
| Court Place Advisors, LLC | 15,133 | $906,769 | 0.32% |
| Ziegler Capital Management, LLC | 123,158 | $7,379,176 | 0.30% |